InvestSMART

Enlitic Inc (ASX:ENL)

ALERT: Price-sensitive ASX Announcement for ENL
Current share price for ENL : $0.005 -0.017 (-77.27%)+
Announcement
Release
24 Dec 2025 9:58AM
Price at Release
$0.022
Full Release
download
Summary
Enlitic, Inc. has secured commitments for an $8 million capital raise through secured convertible notes, with $2.6 million anticipated from an initial tranche and the remainder contingent on shareholder approval. The convertible notes, which mature on 30 September 2026, are convertible into CHESS Depositary Interests (CDIs) at an initial conversion price of A$0.025 per note, transitioning to a 25% discount on the CDIs' 10-day volume-weighted average price post-maturity. Interest rates on these notes are set at 14% per annum until maturity and 18% thereafter. The capital raised is intended to advance Enlitic's AI-enabled healthcare solutions and support operational scalability, enabling the company to maintain strategic growth initiatives despite extending the forecast for achieving cash flow breakeven beyond the current period.
Key Points
  • Enlitic secures $8m through convertible notes with a maturity date of 30 September 2026.
  • Initial tranche of $2.6 million, with $5.4 million subject to shareholder approval.
  • Convertible notes have a 14% annual interest rate until maturity, increasing to 18% thereafter.
  • Conversion price post-maturity is at a 25% discount to the 10-day VWAP of CDIs.
  • Funds will support AI healthcare solutions and operational scaling.
  • Cash flow breakeven timeline extended beyond the current period.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.